The global hormone replacement therapy market attained a value of USD 5.50 billion in 2023 and is projected to reach USD 10.00 billion by 2032, growing at a CAGR of 6.9% over the forecast period of 2024-2032.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Based on the product type, the oestrogen replacement therapy segment held the majority of the market share in 2020. Based on the route of administration, the parenteral segment is estimated to be the leading segment, accounting for the majority of the market share, followed by oral and transdermal methods.
Regionally, the market is segmented into North America, the Asia Pacific, Europe, Latin America, and the Middle East and Africa. North America was the largest market in 2020, accounting for the majority of the market share.
Hormone replacement therapy (HRT) is a treatment used for replenishing the hormones which are present in low levels in the human body. This therapy is particularly favourable for the patients having a deficiency of growth hormone, women in menopausal transition, and geriatric suffering from hypogonadism. It is available in several forms, such as gels, skin, and mouth patches (transdermal), injections, and implants. It is also considered to be a more efficient treatment in comparison to its alternatives, such as chemical drugs, herbal medicines, and others.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
The major product types of the market are:
On the basis of route of administration, the industry can be segmented into:
Based on the type of diseases, the market is divided into:
The EMR report looks into the regional markets like North America, the Asia Pacific, Europe, Latin America, and the Middle East and Africa.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
A rise in the incidences of hormonal imbalance disorders in the neonatal and geriatric populations is primarily driving the market growth. HRT is effective for the treatment of the symptoms of menopause such as night sweats, hot flashes, vaginal dryness, and sexual function. Additionally, it minimises the risk of cardiovascular diseases, vasomotor symptoms, colorectal cancer, and osteoporosis while improving the quality of life. Furthermore, advancements in technology such as the introduction of transdermal drug delivery and new gel-based formulations, coupled with increased investments in research and development activities by the manufacturers are providing a boost to the market growth. Moreover, increasing awareness among the consumers, ageing population, sedentary lifestyles, and the presence of regularly monitored formulations are further expected to stimulate the demand for hormone replacement therapy during the forecast period.
The report presents a detailed analysis of the following key players in the global hormone replacement therapy market, looking into their capacity, market shares, and latest developments like capacity expansions, plant turnarounds, and mergers and acquisitions:
The comprehensive report looks into the macro and micro aspects of the industry. The EMR report gives an in-depth insight into the market by providing a SWOT analysis as well as an analysis of Porter’s Five Forces model.
|Scope of the Report||
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|Breakup by Product||
|Breakup by Route of Administration||
|Breakup by Type of Disease||
|Breakup by End User||
|Breakup by Distribution Channel||
|Breakup by Region||
|Report Price and Purchase Option||Explore our purchase options that are best suited to your resources and industry needs.|
|Delivery Format||Delivered as an attached PDF and Excel through email, with an option of receiving an editable PPT, according to the purchase option.|
*At Expert Market Research, we strive to always give you current and accurate information. The numbers depicted in the description are indicative and may differ from the actual numbers in the final EMR report.
1.1 Objectives of the Study
1.2 Key Assumptions
1.3 Report Coverage – Key Segmentation and Scope
1.4 Research Methodology
2 Executive Summary
3 Global Hormone Replacement Therapy Overview
3.1 Global Hormone Replacement Therapy Market Historical Value (2017-2023)
3.2 Global Hormone Replacement Therapy Market Forecast Value (2024-2032)
4 Global Hormone Replacement Therapy Market Landscape
4.1 Global Hormone Replacement Therapy Developers Landscape
4.1.1 Analysis by Year of Establishment
4.1.2 Analysis by Company Size
4.1.3 Analysis by Region
4.2 Global Hormone Replacement Therapy Product Landscape
4.2.1 Analysis by Patent Type
4.2.2 Analysis by End user
4.2.3 Analysis by Distribution Channel
5 Global Hormone Replacement Therapy Market Dynamics
5.1 Market Drivers and Constraints
5.2 SWOT Analysis
5.3 Porter’s Five Forces Model
5.4 Key Demand Indicators
5.5 Key Price Indicators
5.6 Industry Events, Initiatives, and Trends
5.7 Value Chain Analysis
6 Global Hormone Replacement Therapy Market Segmentation
6.1 Global Hormone Replacement Therapy Market by Product
6.1.1 Market Overview
6.1.2 Estrogen & Progesterone Replacement Therapy
6.1.3 Human Growth Hormone Replacement Therapy
6.1.4 Thyroid Replacement Therapy
6.1.5 Testosterone Replacement Therapy
6.2 Global Hormone Replacement Therapy Market by Route of Administration
6.2.1 Market Overview
6.3 Global Hormone Replacement Therapy Market by Type of Disease
6.3.1 Market Overview
6.3.4 Male Hypogonadism
6.3.5 Growth Hormone Deficiency
6.4 Global Hormone Replacement Therapy Market by End User
6.4.1 Market Overview
6.4.4 Specialty Clinics
6.5 Global Hormone Replacement Therapy Market by Distribution Channel
6.5.1 Market Overview
6.5.2 Hospital Pharmacy
6.5.3 Retail Pharmacy
6.5.4 Online Pharmacy
6.6 Global Hormone Replacement Therapy Market by Region
6.6.1 Market Overview
6.6.2 North America
6.6.4 Asia Pacific
6.6.5 Latin America
6.6.6 Middle East and Africa
7 North America Hormone Replacement Therapy Market
7.1 Market Share by Country
7.2 United States of America
8 Europe Hormone Replacement Therapy Market
8.1 Market Share by Country
8.2 United Kingdom
9 Asia Pacific Hormone Replacement Therapy Market
9.1 Market Share by Country
10 Latin America Hormone Replacement Therapy Market
10.1 Market Share by Country
11 Middle East and Africa Hormone Replacement Therapy Market
11.1 Market Share by Country
11.2 Saudi Arabia
11.3 United Arab Emirates
11.5 South Africa
12 Patent Analysis
12.1 Analysis by Type of Patent
12.2 Analysis by Publication year
12.3 Analysis by Issuing Authority
12.4 Analysis by Patent Age
12.5 Analysis by CPC Analysis
12.6 Analysis by Patent Valuation
12.7 Analysis by Key Players
13 Grants Analysis
13.1 Analysis by year
13.2 Analysis by Amount Awarded
13.3 Analysis by Issuing Authority
13.4 Analysis by Grant Application
13.5 Analysis by Funding Institute
13.6 Analysis by NIH Departments
13.7 Analysis by Recipient Organization
14 Funding Analysis
14.1 Analysis by Funding Instances
14.2 Analysis by Type of Funding
14.3 Analysis by Funding Amount
14.4 Analysis by Leading Players
14.5 Analysis by Leading Investors
14.6 Analysis by Geography
15 Partnership and Collaborations Analysis
15.1 Analysis by Partnership Instances
15.2 Analysis by Type of Partnership
15.3 Analysis by Leading Players
15.4 Analysis by Geography
16 Regulatory Framework
16.1 Regulatory Overview
16.1.1 US FDA
16.1.2 EU EMA
16.1.3 INDIA CDSCO
16.1.4 JAPAN PMDA
17 Supplier Landscape
17.1 Novo Nordisk A/S
17.1.1 Financial Analysis
17.1.2 Product Portfolio
17.1.3 Demographic Reach and Achievements
17.1.4 Mergers and Acquisitions
17.2 Abbott Laboratories Inc.
17.2.1 Financial Analysis
17.2.2 Product Portfolio
17.2.3 Demographic Reach and Achievements
17.2.4 Mergers and Acquisitions
17.3 Pfizer Inc
17.3.1 Financial Analysis
17.3.2 Product Portfolio
17.3.3 Demographic Reach and Achievements
17.3.4 Mergers and Acquisitions
17.4.1 Financial Analysis
17.4.2 Product Portfolio
17.4.3 Demographic Reach and Achievements
17.4.4 Mergers and Acquisitions
17.5 Bayer AG
17.5.1 Financial Analysis
17.5.2 Product Portfolio
17.5.3 Demographic Reach and Achievements
17.5.4 Mergers and Acquisitions
17.6 Merck & Co., Inc.
17.6.1 Financial Analysis
17.6.2 Product Portfolio
17.6.3 Demographic Reach and Achievements
17.6.4 Mergers and Acquisitions
17.7 Viatris Inc.
17.7.1 Financial Analysis
17.7.2 Product Portfolio
17.7.3 Demographic Reach and Achievements
17.7.4 Mergers and Acquisitions
17.8 Eli Lilly and Company
17.8.1 Financial Analysis
17.8.2 Product Portfolio
17.8.3 Demographic Reach and Achievements
17.8.4 Mergers and Acquisitions
17.9 Koninklijke Philips N.V.
17.9.1 Financial Analysis
17.9.2 Product Portfolio
17.9.3 Demographic Reach and Achievements
17.9.4 Mergers and Acquisitions
17.10 F. Hoffmann-La Roche Ltd. (Genentech)
17.10.1 Financial Analysis
17.10.2 Product Portfolio
17.10.3 Demographic Reach and Achievements
17.10.4 Mergers and Acquisitions
17.11 Hisamitsu Pharmaceutical Co., Inc. (Noven Pharmaceuticals, Inc.)
17.11.1 Financial Analysis
17.11.2 Product Portfolio
17.11.3 Demographic Reach and Achievements
17.11.4 Mergers and Acquisitions
17.12 ASCEND Therapeutics US, LLC. (Besins Healthcare)
17.12.1 Financial Analysis
17.12.2 Product Portfolio
17.12.3 Demographic Reach and Achievements
17.12.4 Mergers and Acquisitions
17.13 AbbVie Inc.
17.13.1 Financial Analysis
17.13.2 Product Portfolio
17.13.3 Demographic Reach and Achievements
17.13.4 Mergers and Acquisitions
18 Global Hormone Replacement Therapy Market- Distribution Model (Additional Insight)
18.2 Potential Distributors
18.3 Key Parameters for Distribution Partner Assessment
19 Key Opinion Leaders (KOL) Insights (Additional Insight)
20 Company Competitiveness Analysis (Additional Insight)
20.1 Very Small Companies
20.2 Small Companies
20.3 Mid-Sized Companies
20.4 Large Companies
20.5 Very Large Companies
21 Payment Methods (Additional Insight)
21.1 Government Funded
21.2 Private Insurance
*Additional insights provided are customisable as per client requirements.
In 2023, the global hormone replacement therapy market attained a value of nearly USD 5.50 billion.
The market is projected to grow at a CAGR of 6.9% between 2024 and 2032.
The market is estimated to witness a healthy growth in the forecast period of 2024-2032 to reach about USD 10.00 billion by 2032.
The major drivers of the industry, such as rise in the incidences of hormonal imbalance disorders, increasing awareness among the consumers, ageing population, sedentary lifestyles, and the presence of regularly monitored formulations, are expected to aid the market growth.
The key market trend guiding the growth of the hormone replacement therapy market includes the introduction of transdermal drug delivery and new gel-based formulations.
The major regions in the industry are North America, Latin America, the Middle East and Africa, Europe, and the Asia Pacific, with North America accounting for the largest market share.
The oestrogen replacement therapy segment is the leading product in the industry.
The route of administration is led by parenteral segment in the industry.
The significant types of diseases in the industry are menopause, hypothyroidism, male hypogonadism, and growth hormone deficiency, among others.
The major players in the industry are Abbott, Novo Nordisk A/S, Pfizer Inc, and Allergan, among others.
The global hormone replacement therapy market attained a value of USD 5.50 billion in 2023, driven by the increasing awareness among the consumers. Aided by technological advancements, the market is expected to witness a further growth in the forecast period of 2024-2032, growing at a CAGR of 6.9%. The market is projected to reach USD 10.00 billion by 2032.
EMR’s meticulous research methodology delves deep into the market, covering the macro and micro aspects of the industry. Based on its product type, the oestrogen replacement therapy segment is the dominant product in the industry. On the basis of route of administration, the parenteral segment is the leading segment. On the basis of type of disease, the industry is divided into menopause, hypothyroidism, male hypogonadism, growth hormone deficiency, and others. The major regional markets for hormone replacement therapy are North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa, with North America accounting for the largest share of the industry. The key players in the above industry include Abbott, Novo Nordisk A/S, Pfizer Inc, Allergan, and others.
EMR’s research methodology uses a combination of cutting-edge analytical tools and the expertise of their highly accomplished team, thus, providing their customers with industry insights that are accurate, actionable, and help them remain ahead of their competition.
Single User License
Five User License
We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.
We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.
We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.
Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.